Citigroup’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-139,224
Closed -$32K 5086
2024
Q4
$32K Buy
139,224
+138,537
+20,166% +$31.8K ﹤0.01% 4344
2024
Q3
$1.48K Buy
+687
New +$1.48K ﹤0.01% 4608
2024
Q2
Sell
-33,624
Closed -$180K 4921
2024
Q1
$180K Buy
+33,624
New +$180K ﹤0.01% 3332
2022
Q4
Sell
-111
Closed -$1K 5084
2022
Q3
$1K Sell
111
-90
-45% -$811 ﹤0.01% 4876
2022
Q2
$2K Sell
201
-161
-44% -$1.6K ﹤0.01% 5133
2022
Q1
$4K Sell
362
-1,291
-78% -$14.3K ﹤0.01% 5100
2021
Q4
$54K Buy
1,653
+683
+70% +$22.3K ﹤0.01% 4260
2021
Q3
$43K Buy
970
+321
+49% +$14.2K ﹤0.01% 4078
2021
Q2
$35K Buy
649
+219
+51% +$11.8K ﹤0.01% 4322
2021
Q1
$32K Sell
430
-12,470
-97% -$928K ﹤0.01% 4310
2020
Q4
$1.4M Buy
12,900
+12,246
+1,872% +$1.33M ﹤0.01% 1945
2020
Q3
$58K Sell
654
-6,396
-91% -$567K ﹤0.01% 3418
2020
Q2
$752K Buy
7,050
+5,787
+458% +$617K ﹤0.01% 2301
2020
Q1
$75K Buy
1,263
+239
+23% +$14.2K ﹤0.01% 3496
2019
Q4
$71K Buy
1,024
+652
+175% +$45.2K ﹤0.01% 3748
2019
Q3
$39K Sell
372
-697
-65% -$73.1K ﹤0.01% 3897
2019
Q2
$99K Buy
1,069
+332
+45% +$30.7K ﹤0.01% 3642
2019
Q1
$68K Buy
737
+88
+14% +$8.12K ﹤0.01% 3831
2018
Q4
$36K Sell
649
-46
-7% -$2.55K ﹤0.01% 4118
2018
Q3
$83K Buy
+695
New +$83K ﹤0.01% 3718
2018
Q2
Sell
-193
Closed -$25K 5105
2018
Q1
$25K Buy
193
+173
+865% +$22.4K ﹤0.01% 4124
2017
Q4
$2K Buy
+20
New +$2K ﹤0.01% 4825
2017
Q3
Sell
-8
Closed -$1K 4895
2017
Q2
$1K Sell
8
-4
-33% -$500 ﹤0.01% 4767
2017
Q1
$2K Buy
+12
New +$2K ﹤0.01% 4657
2016
Q4
Sell
-38
Closed -$5K 4981
2016
Q3
$5K Buy
+38
New +$5K ﹤0.01% 4661